New Sanitized MedX 200s active ingredient series to reduce risk of HAI

NewsGuard 100/100 Score

The new Sanitized® MedX 200s active ingredient series, which has been used with success in the plastics of medical equipment, makes a contribution to reducing the risk of Healthcare-Associated Infections, HAI.

The results from current studies underscore that even the antibiotic resistant bacteria strain NDM-1 can be contained. These studies were carried out by an independent laboratory in London, UK. The first tests already confirmed the effectiveness against MRSA as well as against antibiotic resistant bacteria. SANITIZED also identified other active substances with a very interesting profile against the same bacteria.

The active ingredients imbedded in the polymers inhibit the growth of bacteria populations on the surface of treated medical devices—durably and reliably.

"We intend to extend our Sanitized® MedX 200s portfolio soon. This will allow us to enlarge our offer in medical device applications, including textile applications," explained Dr. Bruno Piastra, Product Manager Polymer Additives at SANITIZED. The medical device sector was designated as a business pillar in our growth strategy for the next years.

Source:

SANITIZED AG

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
MSU team creates a promising vaccine candidate for antibiotic-resistant bacteria